Product Detail
Sarafloxacin-d8 Hydrochloride Trihydrate
Sarafloxacin Stable Isotopes
Stock Status: In Stock
Login to view price
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
Sarafloxacin
Storage
Store at refrigerator (2-8°C) for long term storage
Hazard Information
Refer MSDS for accurate information.
Sarafloxacin-d8 Hydrochloride Trihydrate Product Information
Sarafloxacin-d8 Hydrochloride Trihydrate is listed under Stable Isotopes. It is associated with Sarafloxacin and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-W-00346.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Sarafloxacin-d8 Hydrochloride Trihydrate
CAS No.
2733145-07-6 (anhydrous)
CAT No.
CS-W-00346
Molecular Formula
C20H16D8ClF2N3O6
Molecular Weight
483.92
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
SMILES
O=C(O)C1=CN(C2=C(C1=O)C=C(C(N3C([2H])(C([2H])(NC([2H])(C3([2H])[2H])[2H])[2H])[2H])=C2)F)C4=CC=C(C=C4)F.Cl[H].[H]O[H].[H]O[H].[H]O[H]
IUPAC Name
6-fluoro-1-(4-fluorophenyl)-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride trihydrate-d8
Purity by HPLC
Not less than 90 %
Hazard Compound
Refer MSDS for accurate information.
Description
Overview
"Labeled Sarafloxacin, intended for use as an internal standard for the quantification of Sarafloxacin by GC- or LC-mass spectrometry."
Synonyms
6-fluoro-1-(4-fluorophenyl)-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride trihydrate-d8
Application Notes
"Labeled Sarafloxacin, intended for use as an internal standard for the quantification of Sarafloxacin by GC- or LC-mass spectrometry."
References
"Fernandes, P,B,, et al,: Antimicrob, Ag, Chemother,, 29, 201 (1986), Digranes, A,, et al,: Chemotherapy, 34, 298 (1988),"
